Fresenius Stock Price, News & Analysis (OTCMKTS:FSNUY)

$20.16 0.18 (0.90 %)
(As of 01/17/2018 01:03 AM ET)
Previous Close$20.02
Today's Range$19.94 - $20.16
52-Week Range$17.92 - $22.30
Volume73,382 shs
Average Volume28,647 shs
Market Capitalization$44.31 billion
P/E RatioN/A
Dividend Yield0.56%
Beta-1.74

About Fresenius (OTCMKTS:FSNUY)

Fresenius logoFresenius SE & Co. KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed segments. The Fresenius Medical Care segment offers products for patients with chronic kidney failure. This segment offers dialyzers, dialysis machines, and renal pharmaceuticals, as well as dialysis- related services. The Fresenius Kabi segment specializes in the therapy and care of chronically and critically ill patients. This segment offers IV drugs comprising intravenously administered generic anesthetics, analgesics, anti-infectives, and drugs for the treatment of oncological and other critical diseases; parenteral and enteral nutrition products; infusion solutions and blood volume substitutes for infusion therapy; infusion and nutrition pumps, as well as consumables; and products used in the collection and processing whole blood and blood components, as well as in transfusion medicine. The Fresenius Helios segment operates approximately 112 hospitals, including 88 acute care hospitals and 24 post-acute care clinics; 78 outpatient clinics; 4 out-patient post-acute care centers; 18 prevention centers; and 13 nursing homes. This segment has approximately 35,000 beds. The Fresenius Vamed segment manages projects and provides services for hospitals and other health care facilities. This segment offers project development, planning, and turnkey construction services, as well as provides maintenance, technical management, and operational management services. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg, Germany.

Receive FSNUY News and Ratings via Email

Sign-up to receive the latest news and ratings for FSNUY and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:FSNUY
CUSIPN/A
Phone49-6172-6080

Debt

Debt-to-Equity Ratio0.78%
Current Ratio1.21%
Quick Ratio0.91%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$31.67 billion
Price / Sales1.41
Cash Flow$1.40 per share
Price / Cash14.42
Book Value$10.32 per share
Price / Book1.95

Profitability

Trailing EPSN/A
Net Income$1.76 billion
Net Margins5.28%
Return on Equity9.43%
Return on Assets3.85%

Miscellaneous

Employees232,873
Outstanding Shares2,218,140,000

Fresenius (OTCMKTS:FSNUY) Frequently Asked Questions

What is Fresenius' stock symbol?

Fresenius trades on the OTCMKTS under the ticker symbol "FSNUY."

How often does Fresenius pay dividends? What is the dividend yield for Fresenius?

Fresenius announced a None dividend on Thursday, June 29th. Shareholders of record on Wednesday, May 17th will be paid a dividend of $0.112 per share on Wednesday, May 24th. The ex-dividend date of this dividend is Monday, May 15th. View Fresenius' Dividend History.

How were Fresenius' earnings last quarter?

Fresenius SE (OTCMKTS:FSNUY) announced its quarterly earnings data on Friday, November, 3rd. The company reported $0.21 earnings per share (EPS) for the quarter. Fresenius had a return on equity of 9.43% and a net margin of 5.28%. View Fresenius' Earnings History.

When will Fresenius make its next earnings announcement?

Fresenius is scheduled to release their next quarterly earnings announcement on Wednesday, February, 28th 2018. View Earnings Estimates for Fresenius.

Who are some of Fresenius' key competitors?

How do I buy Fresenius stock?

Shares of Fresenius can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Fresenius' stock price today?

One share of Fresenius stock can currently be purchased for approximately $20.16.

How big of a company is Fresenius?

Fresenius has a market capitalization of $44.31 billion and generates $31.67 billion in revenue each year. Fresenius employs 232,873 workers across the globe.

How can I contact Fresenius?

Fresenius' mailing address is Else-Kroner-Strasse 1, Bad Homburg 2M, 61352. The company can be reached via phone at 49-6172-6080 or via email at [email protected]


MarketBeat Community Rating for Fresenius (FSNUY)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  63 (Vote Outperform)
Underperform Votes:  77 (Vote Underperform)
Total Votes:  140
MarketBeat's community ratings are surveys of what our community members think about Fresenius and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Fresenius (OTCMKTS:FSNUY) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: N/AN/AN/AN/A
Consensus Rating Score: N/AN/AN/AN/A
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/AN/AN/A
Price Target Upside: N/AN/AN/AN/A

Fresenius (OTCMKTS:FSNUY) Consensus Price Target History

Price Target History for Fresenius (OTCMKTS:FSNUY)

Fresenius (OTCMKTS:FSNUY) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
4/11/2016Sanford C. BernsteinInitiated CoverageOutperformView Rating Details
3/17/2016NomuraInitiated CoverageNeutralView Rating Details
2/12/2016Berenberg BankUpgradeHold -> BuyView Rating Details
(Data available from 1/17/2016 forward)

Earnings

Fresenius (OTCMKTS:FSNUY) Earnings History and Estimates Chart

Earnings by Quarter for Fresenius (OTCMKTS:FSNUY)

Fresenius (OTCMKTS FSNUY) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/28/2018        
11/3/2017Q3 2017$0.21ViewN/AView Earnings Details
5/3/2017Q1 2017$0.22ViewN/AView Earnings Details
2/22/2017Q4 2016$0.22ViewN/AView Earnings Details
11/1/2016Q3 2016$0.20ViewN/AView Earnings Details
8/5/2016Q2 2016$0.20ViewN/AView Earnings Details
5/6/2016Q1 2016$0.18ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Fresenius (OTCMKTS:FSNUY) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Fresenius (OTCMKTS:FSNUY) Dividend Information

Most Recent Dividend:5/24/2017
Annual Dividend:$0.11
Dividend Yield:0.55%
Payout Ratio:
Dividend Payments by Quarter for Fresenius (OTCMKTS:FSNUY)

Fresenius (OTCMKTS:FSNUY) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/29/2017None$0.115/15/20175/17/20175/24/2017
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Fresenius (OTCMKTS FSNUY)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

Fresenius (OTCMKTS FSNUY) News Headlines

Source:

SEC Filings

Fresenius (OTCMKTS:FSNUY) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Fresenius (OTCMKTS FSNUY) Stock Chart for Wednesday, January, 17, 2018

Loading chart…

This page was last updated on 1/17/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.